REVESTIVE subst sèche 5 mg c solv flac 28 pce
7680657390018
CH-65739
A16AX08
04.09.0.
1 / 3
google
Details
- Product number
- 6573901
- CPT
- -
- Packaging group
- 28
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: teduglutidum 5 mg, histidinum, mannitolum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii hydroxidum, acidum hydrochloridum, pro vitro corresp. natrium 0.7 mg. Solvens: aqua ad iniectabile 0.5 ml, pro vitro.
Articles (1)
Revestive 5 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
28
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
aqua ad iniectabile
|
0.5 ML | Substance | HNIDK |
|
teduglutidum
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
histidinum
|
- | Substance | HNIDK |
|
mannitolum
|
- | Substance | HNIDK |
|
natrii dihydrogenophosphas monohydricus
|
- | Substance | HNIDK |
|
dinatrii phosphas heptahydricus
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
natrium
|
0.7 MG | Substance | HBESI |
Authorization holder
Takeda Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 65739
- Drug name
- Revestive, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
- Galenic form
- PULMJ
- ATC Code
- A16AX08
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 01/09/2016
- Authorization expiration date
- 31/12/9999
- IT number
- 04.09.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- REVESTIVE subst sèche 5 mg c solv flac 28 pce
- Description (DE)
- REVESTIVE Trockensub 5 mg c Solv Durchstf 28 Stk
- Market launch
- 01/09/2016
- Narcotic (BTM)
- No